[Study on cytomedicine of alginate-poly(L) lysine-alginate microencapsulated hybridoma cells].
OBJECTIVE
To study the cytomedicine of alginate-poly (L) lysine-alginate (APA) microencapsulated hybridoma cells and their characteristics.


METHODS
The spleen cells taken from BALB/C mice immunized with purified human IgG1 kappa type were fused with mouse myeloma cells SP2/0. The hybridoma cell lines secreting monoclonal antibodies (mAb) against human IgG1 kappa type was named JY-A1. The APA microencapsulated JY-A1 cells were prepared with a high-voltage electrostatic system. Microencapsulation parameters were optimized and their morphology was studied. The mechanical strength and chemical intensity of microcapsules were measured. The mAb secrete from APA microencapsulated JY-A1 cells was determined by ELISA kit. The microcapsules injected into mice abdominal cavity previously were recovered at intervals.


RESULTS
The microcapsules prepared in the same condition of the high-voltage electrostatic system were round and homogeneous. The mAb secreted by the microencapsulated JY-A1 cells were shown to permeate the membranes of APA microcapsules in vitro. After an intraperitoneal injection to mice, APA microcapsules were recovered on day 7, 14, 28, 56. The electron microscopy study revealed that the majority of recovered microcapsules were intact, and no evidence of immunological reaction in terms of fibrosis.


CONCLUSIONS
APA microencapsulated hybridoma cells prepared by high-voltage electrostatic system have good mechanical strength and chemical intensity. The APA microencapsulated hybridoma cells can maintain physiological functions in vitro, and the microcapsules have good biocompatibility in vivo.
Zhao
Dai-jian
DJ
College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 30031, China.
Jin
Yi
Y
Fu
Hong-xing
HX
Chen
Ping
P
D000464:Alginates; D000818:Animals; D000911:Antibodies, Monoclonal / Q000096:biosynthesis*; D001672:Biocompatible Materials; D002214:Capsules; D005260:Female; D006825:Hybridomas / Q000378:metabolism; D008567:Membranes, Artificial; D051379:Mice; D008807:Mice, Inbred BALB C; D009101:Multiple Myeloma / Q000473:pathology; D010316:Particle Size; D011107:Polylysine / Q000031:analogs & derivatives*; D013154:Spleen / Q000166:cytology / Q000276:immunology
D000464:Alginates; D000911:Antibodies, Monoclonal; D001672:Biocompatible Materials; D002214:Capsules; D008567:Membranes, Artificial; C051546:alginate-polylysine-alginate; D011107:Polylysine